A trial funded by Nestle has found that infant formula enriched with milk-derived oligosaccharides (MOS), a prebiotic, has helped to improve gut microbiota in babies, such as increasing the abundance of Bifidobacterium.
You May Also Like
Dairy industryIndustry newsInfant formulaMedia ReleaseToddler Milk Response to questions from the ABC 7.30 Report on questions about toddler milk drinks
INCFebruary 26, 2024
Dairy industryIndustry newsInfant formula Bifidobacterium probiotic may incur “remarkable” benefits to infant gut, study finds
INCMarch 27, 2023






